Texture image


Varian, Standard Imaging and TomoTherapy Elected to ASTRO’s 2006 Corporate Advisory Council

Posted: Feb 12th, 2006

The American Society for Therapeutic Radiology and Oncology is pleased to announce that TomoTherapy Inc., Varian Medical Systems, Inc., and Standard Imaging have been elected to serve three-year terms on ASTRO's Corporate Advisory Council. These companies were elected by ASTRO's corporate membership and approved by the Society's Board of Directors.

ASTRO truly values the input from our industry partners, said Mary Austin-Seymour, M.D., Chair of ASTRO's Corporate Relations Committee and a radiation oncologist at the University of Washington Medical Center in Seattle. They provide us with resources to implement programs and educational opportunities that allow us to help our doctors better serve their patients.

The Corporate Advisory Council is a representative group of ASTRO's nearly 100 corporate members, with a proportional mix of both large and small companies. The goal of the council is to focus on issues of mutual concern to all corporate members and to increase awareness of radiation therapy and advance the science and practice of radiation therapy in the treatment of cancer.

The complete council listing with the date their term expires is as follows:

  • Best Medical International 2006
  • CMS, Inc. 2006
  • Elekta, Inc. 2006
  • Imclone Medical Systems 2007
  • Multidata Systems 2007
  • NOMOS Radiation Oncology
  • A division of North American Scientific 2007
  • Standard Imaging 2008
  • TomoTherapy Inc. 2008
  • Varian Medical Systems, Inc. 2008

To learn more about ASTRO's Corporate Member program, visit http://www.astro.org/corporate_relations/. For more information on radiation therapy for cancer, please visit http://www.rtanswers.org.

ASTRO is the largest radiation oncology society in the world, with more than 8,500 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to the advancement of the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving healthcare environment.

Join our Mailing List